前生物技术专家George Tidmarsh 选来领导林业发展局的药物评估中心。 Former biotech exec George Tidmarsh picked to lead FDA's drug evaluation center.

美国食品和药物管理局(FDA)计划任命前生物技术执行官和儿科专家乔治·蒂德马什担任药物评价和研究中心新主任。 The U.S. Food and Drug Administration (FDA) plans to appoint George Tidmarsh, a former biotech executive and pediatric specialist, as the new director of the Center for Drug Evaluation and Research. Tidmarsh创立并领导了数家制药公司,他将监督美国所有药物的安全和功效。 Tidmarsh, who has founded and led several pharmaceutical companies, will oversee the safety and efficacy of all U.S. drugs. 此次任命是在 FDA 最近的领导层变动之后做出的，包括该中心代理主任的退休。 This appointment follows recent leadership changes at the FDA, including the retirement of the center's acting director.